feed,title,long_url,short_url
Benzinga,Iovance Biotherapeutics Pushes FDA Rolling Submission Deadline Into Next Year For Its Lead Skin Cancer Candidate,https://benzinga.com/general/biotech/22/11/29783057/iovance-biotherapeutics-pushes-fda-rolling-submission-deadline-into-next-year-for-its-lead-skin-c,https://bit.ly/3UW2PCI
